Inovio Pharmaceuticals Stock Analysis

Inovio Stock Analysis Notes

About 17.0% of the company shares are owned by institutional investors. The book value of Inovio Pharmaceuticals was currently reported as 5.15. The company recorded a loss per share of 6.09. Inovio Pharmaceuticals had not issued any dividends in recent years. The entity had 1:12 split on the 25th of January 2024. Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus , cancer, and infectious diseases. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania. Inovio Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 317 people. To learn more about Inovio Pharmaceuticals call Joseph Kim at 267 440 4200 or check out https://www.inovio.com.

Inovio Pharmaceuticals Investment Alerts

Inovio Pharmaceuticals Upcoming and Recent Events

Inovio Largest EPS Surprises

View All Earnings Estimates

Inovio Pharmaceuticals Thematic Classifications

Inovio Stock Institutional Investors

Note, although Inovio Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Inovio Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 268.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inovio Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Inovio Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Inovio Profitablity

Management Efficiency

Inovio Pharmaceuticals has Return on Asset of (0.3211) % which means that on every $100 spent on assets, it lost $0.3211. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.7955) %, meaning that it generated no profit with money invested by stockholders. Inovio Pharmaceuticals' management efficiency ratios could be used to measure how well Inovio Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to drop to -0.82. In addition to that, Return On Capital Employed is likely to drop to -1.09. At this time, Inovio Pharmaceuticals' Non Current Assets Total are very stable compared to the past year. As of the 25th of April 2024, Other Current Assets is likely to grow to about 6.9 M, while Total Assets are likely to drop about 131.1 M.

Technical Drivers

As of the 25th of April, Inovio Pharmaceuticals retains the Downside Deviation of 5.68, market risk adjusted performance of 0.2402, and Risk Adjusted Performance of 0.0644. Inovio Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Inovio Pharmaceuticals, which can be compared to its competitors. Please check out Inovio Pharmaceuticals standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Inovio Pharmaceuticals is priced fairly, providing market reflects its last-minute price of 10.16 per share. Given that Inovio Pharmaceuticals has jensen alpha of 0.3669, we strongly advise you to confirm Inovio Pharmaceuticals's regular market performance to make sure the company can sustain itself at a future point.

Inovio Pharmaceuticals Price Movement Analysis

Inovio Pharmaceuticals Insider Trading Activities

Inovio Pharmaceuticals Predictive Daily Indicators

Inovio Pharmaceuticals Corporate Filings

Inovio Pharmaceuticals Forecast Models

Inovio Pharmaceuticals' time-series forecasting models are one of many Inovio Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inovio Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Inovio Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Inovio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Inovio Pharmaceuticals. By using and applying Inovio Stock analysis, traders can create a robust methodology for identifying Inovio entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inovio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Inovio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Inovio Pharmaceuticals stock analysis indicators help investors evaluate how Inovio Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Inovio Pharmaceuticals shares will generate the highest return on investment. By understating and applying Inovio Pharmaceuticals stock analysis, traders can identify Inovio Pharmaceuticals position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

When running Inovio Pharmaceuticals' price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.